Title: 3 SENATE BILL NO. 109 By: Stanley of the Senate
Official Title: 3 SENATE BILL NO. 109 By: Stanley of the Senate
Number of Sections: 1
Source: versions - Floor (Senate)
Media Type: application/pdf
Strikethrough Detection: 3 sections found

================================================================================

Section 1:
1 SENATE FLOOR VERSION
February 20, 2025
2
4 and
5 Miller of the House
6
7
8 An Act relating to health insurance; defining terms;
requiring coverage of certain genetic testing and
9 cancer imaging; specifying terms of coverage;
providing certain exclusions; providing for
10 codification; and providing an effective date.
11
12
13 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
14 SECTION 1. NEW LAW A new section of law to be codified
15 in the Oklahoma Statutes as Section 6060.5b of Title 36, unless
16 there is created a duplication in numbering, reads as follows:
17 A. For the purposes of this section:
18 1. “Clinical utility” means clinical utility as defined
19 pursuant to Section 6060.5a of Title 36 of the Oklahoma Statutes;
20 2. “Evidence-based cancer imaging” means appropriate
21 preventative screening and imaging supported by evidence;
22 3. “Genetic testing for an inherited mutation” means multi-gene
23 testing for an inherited mutation associated with an increased risk
24 of cancer;
SENATE FLOOR VERSION - SB109 SFLR Page 1
(Bold face denotes Committee Amendments)
1 4. “Health benefit plan” means a health benefit plan as defined
2 pursuant to Section 6060.4 of Title 36 of the Oklahoma Statutes; and
3 5. “Health care provider” means any physician, hospital, or
4 other entity or person that is licensed or otherwise authorized in
5 this state to furnish health care services.
6 B. Any health benefit plan including the Oklahoma Employees
7 Insurance Plan that is offered, issued, or renewed in this state on
8 or after the effective date of this act shall provide coverage for:
9 1. Clinical genetic testing for an inherited gene mutation for
10 individuals with a personal or family history of cancer when such
11 test provides clinical utility and when ordered or recommended by a
12 health care provider in accordance with medical and scientific
13 evidence including, but not limited to:
14 a. the most recent version of the National Comprehensive
15 Cancer Network (NCCN) clinical practice
16 recommendations that are Category 2A or higher,
17 b. Centers for Medicare and Medicaid Services national
18 coverage determinations or Medicare administrative
19 contractor local coverage determinations, or
20 c. nationally recognized clinical practice guidelines;
21 and
22 2. Evidence-based cancer imaging for individuals with an
23 increased risk of cancer when such test provides clinical utility
24 and when ordered or recommended by a health care provider in
SENATE FLOOR VERSION - SB109 SFLR Page 2
(Bold face denotes Committee Amendments)
1 acco rdance with the most recent version of the NCCN clinical
2 practice recommendations that are Category 2A or higher, or in
3 accordance with other nationally recognized clinical practice
4 guidelines.
5 C. Coverage under this section shall not be subject to any
6 annual deductibles, copayments, or coinsurance limits as established
7 for all covered benefits under the health benefit plan.
8 D. If application of this section would result in health
9 savings account ineligibility under Section 223 of the Internal
10 Revenue Code of 1986, as amended, the provisions of this section
11 shall only apply to health savings accounts with qualified high
12 deductible health plans with respect to the deductible of such a
13 plan after the enrollee has satisfied the minimum deductible.
14 Provided, however, the provisions of this section shall apply to
15 items or services that are preventive care pursuant to Section
16 223(c)(2)(C) of the Internal Revenue Code of 1986, as amended,
17 regardless of whether the minimum deductible has been satisfied.
18 SECTION 2. This act shall become effective November 1, 2025.
19 COMMITTEE REPORT BY: COMMITTEE ON BUSINESS AND INSURANCE
February 20, 2025 - DO PASS
20
21
22
23
24
SENATE FLOOR VERSION - SB109 SFLR Page 3
(Bold face denotes Committee Amendments)
[DELETED: P B S  a M]
[DELETED: P t C n]
[DELETED: P]


================================================================================

Raw Text:
1 SENATE FLOOR VERSION
February 20, 2025
2
3 SENATE BILL NO. 109 By: Stanley of the Senate
4 and
5 Miller of the House
6
7
8 An Act relating to health insurance; defining terms;
requiring coverage of certain genetic testing and
9 cancer imaging; specifying terms of coverage;
providing certain exclusions; providing for
10 codification; and providing an effective date.
11
12
13 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
14 SECTION 1. NEW LAW A new section of law to be codified
15 in the Oklahoma Statutes as Section 6060.5b of Title 36, unless
16 there is created a duplication in numbering, reads as follows:
17 A. For the purposes of this section:
18 1. “Clinical utility” means clinical utility as defined
19 pursuant to Section 6060.5a of Title 36 of the Oklahoma Statutes;
20 2. “Evidence-based cancer imaging” means appropriate
21 preventative screening and imaging supported by evidence;
22 3. “Genetic testing for an inherited mutation” means multi-gene
23 testing for an inherited mutation associated with an increased risk
24 of cancer;
SENATE FLOOR VERSION - SB109 SFLR Page 1
(Bold face denotes Committee Amendments)

1 4. “Health benefit plan” means a health benefit plan as defined
2 pursuant to Section 6060.4 of Title 36 of the Oklahoma Statutes; and
3 5. “Health care provider” means any physician, hospital, or
4 other entity or person that is licensed or otherwise authorized in
5 this state to furnish health care services.
6 B. Any health benefit plan including the Oklahoma Employees
7 Insurance Plan that is offered, issued, or renewed in this state on
8 or after the effective date of this act shall provide coverage for:
9 1. Clinical genetic testing for an inherited gene mutation for
10 individuals with a personal or family history of cancer when such
11 test provides clinical utility and when ordered or recommended by a
12 health care provider in accordance with medical and scientific
13 evidence including, but not limited to:
14 a. the most recent version of the National Comprehensive
15 Cancer Network (NCCN) clinical practice
16 recommendations that are Category 2A or higher,
17 b. Centers for Medicare and Medicaid Services national
18 coverage determinations or Medicare administrative
19 contractor local coverage determinations, or
20 c. nationally recognized clinical practice guidelines;
21 and
22 2. Evidence-based cancer imaging for individuals with an
23 increased risk of cancer when such test provides clinical utility
24 and when ordered or recommended by a health care provider in
SENATE FLOOR VERSION - SB109 SFLR Page 2
(Bold face denotes Committee Amendments)

1 acco rdance with the most recent version of the NCCN clinical
2 practice recommendations that are Category 2A or higher, or in
3 accordance with other nationally recognized clinical practice
4 guidelines.
5 C. Coverage under this section shall not be subject to any
6 annual deductibles, copayments, or coinsurance limits as established
7 for all covered benefits under the health benefit plan.
8 D. If application of this section would result in health
9 savings account ineligibility under Section 223 of the Internal
10 Revenue Code of 1986, as amended, the provisions of this section
11 shall only apply to health savings accounts with qualified high
12 deductible health plans with respect to the deductible of such a
13 plan after the enrollee has satisfied the minimum deductible.
14 Provided, however, the provisions of this section shall apply to
15 items or services that are preventive care pursuant to Section
16 223(c)(2)(C) of the Internal Revenue Code of 1986, as amended,
17 regardless of whether the minimum deductible has been satisfied.
18 SECTION 2. This act shall become effective November 1, 2025.
19 COMMITTEE REPORT BY: COMMITTEE ON BUSINESS AND INSURANCE
February 20, 2025 - DO PASS
20
21
22
23
24
SENATE FLOOR VERSION - SB109 SFLR Page 3
(Bold face denotes Committee Amendments)

[DELETED: P B S  a M]
[DELETED: P t C n]
[DELETED: P]